Fonar (NASDAQ:FONR) Stock Price Passes Below 200-Day Moving Average - Time to Sell?

Fonar Corporation (NASDAQ:FONR - Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $15.19 and traded as low as $14.50. Fonar shares last traded at $14.52, with a volume of 27,554 shares.Wall Street Analyst Weigh InFONR has been the subject of several research reports. Wall Street Zen raised Fonar to a "hold" rating in a research report on Friday, November 28th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Fonar in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".Check Out Our Latest Analysis on FONRFonar Stock Down 2.3%The company's fifty day moving average price is $14.79 and its 200-day moving average price is $15.19. The stock has a market capitalization of $90.02 million, a PE ratio of 13.08 and a beta of 1.00. Fonar (NASDAQ:FONR - Get Free Report) last posted its quarterly earnings data on Monday, November 10th. The medical equipment provider reported $0.34 earnings per share for the quarter. The company had revenue of $26.04 million during the quarter. Fonar had a return on equity of 4.66% and a net margin of 7.08%.Hedge Funds Weigh In On FonarA number of hedge funds have recently bought and sold shares of the company. Money Concepts Capital Corp grew its position in Fonar by 4.5% during the 3rd quarter. Money Concepts Capital Corp now owns 483,522 shares of the medical equipment provider's stock valued at $7,282,000 after purchasing an additional 20,762 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Fonar by 1.2% in the third quarter. Dimensional Fund Advisors LP now owns 376,976 shares of the medical equipment provider's stock worth $5,677,000 after buying an additional 4,413 shares in the last quarter. Bridgeway Capital Management LLC lifted its stake in shares of Fonar by 2.3% in the second quarter. Bridgeway Capital Management LLC now owns 83,382 shares of the medical equipment provider's stock worth $1,247,000 after buying an additional 1,843 shares in the last quarter. Empowered Funds LLC grew its holdings in shares of Fonar by 7.7% during the first quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider's stock valued at $296,000 after buying an additional 1,504 shares during the last quarter. Finally, Ritholtz Wealth Management increased its position in shares of Fonar by 66.4% during the third quarter. Ritholtz Wealth Management now owns 17,417 shares of the medical equipment provider's stock valued at $262,000 after acquiring an additional 6,948 shares in the last quarter. Institutional investors own 50.64% of the company's stock. Fonar Company Profile (Get Free Report)Fonar Corporation is a medical technology company primarily engaged in the design, manufacture and sale of magnetic resonance imaging (MRI) systems. The company's flagship product, the UPRIGHT® Multi-Position™ MRI, enables patients to be scanned in standing, seated and traditional recumbent positions, offering enhanced diagnostic capabilities for musculoskeletal, neurological and vascular conditions. In addition to MRI equipment sales, Fonar provides equipment installation, training and maintenance services to hospitals, imaging centers and private practices. Headquartered in Melville, New York, Fonar markets its MRI systems both domestically and internationally, supported by a network of service engineers and customer support personnel.Featured ArticlesFive stocks we like better than FonarThe boring AI play that could pay up to $4,290 monthlyTrump’s “real estate deal for America” explainedPut $1,000 into this stock by Jan 1 [Not NVDA]ALERT: Drop these 5 stocks before January 2026!Trump Did WHAT??This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Fonar Right Now?Before you consider Fonar, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fonar wasn't on the list.While Fonar currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here